Bani Tchekanova, PhD, MS
SVP, Global Regulatory Affairs
Dr. Tchekanova has extensive experience in the oncology and cardiovascular pharmaceutical industries with global Regulatory Affairs, strategic Quality Assurance and clinical research. With over 25 years experience, she previously served as VP, Regulatory Affairs and Clinical Operations at Statera Biopharmaceutical, providing strategic oversight for the clinical operations, pharmacovigilance, safety reporting and Regulatory operations. As VP, Regulatory Affairs, Clinical Operations, and Quality Assurance at Collidion, Dr. Tchekanova provided development and strategy inputs, assuring compliance with successful submissions for approvals to health authorities. Prior to that, she was Senior Consultant at PAREXEL, Director, Clinical Operations at Artemis, Director, Regulatory Affairs at EMD Serono, Head, International Labeling Operation at Boehringer Ingelheim, and Manager, Regulatory Affairs at Abbott. Dr. Tchekanova received her PhD in Molecular Biology, an MS in Clinical Laboratory Sciences and a BS in Biology and Chemistry from University of Wisconsin-Milwaukee.